While DLBCL research has largely focused on total NF-κB activation resulting from mutations within these pathways, there is growing evidence that the composition of NF-κB within DLBCL is functionally important (42, 43). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.